THE JOHN GOLDMAN AWARD 2022 was presented to Dr. Naranie Shanmuganathan, Royal Adelaide Hospital, Adelaide, Australia, for her two-year project on: “Comprehensive and sensitive genomic characterisation of diverse mutation types associated with treatment resistance for patients with CML using an RNA-based model” | ![]() |
THE JOHN GOLDMAN AWARD 2021 was presented to Dr. Emmanuelle Clappier, Dept. of Haematology, Saint-Louis Hospital, Paris, France, for her two-year project on “Biological significance of BCR-ABL1 clonal hematopoiesis in Ph-positive acute lymphoblastic leukemia (Ph+ ALL): relevance for treatment-free remission“ | ![]() |
THE JOHN GOLDMAN AWARD 2020 was presented to Dr. Vaidehi Krishnan, Laboratory of Hematological Malignancies, DUKE-NUS, Singapore, for her two-year project on “High dimensional single cell analysis to predict TFR at the time of CML diagnosis” | ![]() |
THE JOHN GOLDMAN AWARD 2019 was presented to Dr. Ilaria Pagani, Leukaemia Research Group, Cancer Program, SAHMRI, Adelaide, Australia for her two-year project on the "Use of machine learning to integrate clinical data and biomarkers to optimise prediction of TFR". | ![]() |
Jorge Cortes (Augusta, USA) Michael Hallek (Cologne, Germany) Hervé Dombret (Paris, France) |
Andreas Hochhaus (Jena, Germany) Daniela S. Krause (Frankfurt, Germany) Alessandro Vannucchi (Florence, Italy) Andrew Rawstron (Leeds, UK) |